White matter lesions as a prognostic marker of recurrence in cryptogenic stroke with high-risk patent foramen ovale

被引:0
作者
Niiyama, Shunichi [1 ]
Ueno, Yuji [1 ,2 ]
Kurita, Naohide [3 ]
Nakajima, Sho [3 ]
Kijima, Chikage [1 ]
Hira, Kenichiro [1 ]
Miyamoto, Nobukazu [1 ]
Watanabe, Masao [3 ]
Yamashiro, Kazuo [3 ]
Urabe, Takao [3 ]
Hattori, Nobutaka [1 ]
机构
[1] Juntendo Univ, Dept Neurol, Sch Med, Hongo 2-1-1,Bunkyo Ku, Tokyo 1138421, Japan
[2] Univ Yamanashi, Dept Neurol, Shimokato 1110, Yamanashi 4093898, Japan
[3] Juntendo Univ, Dept Neurol, Urayasu Hosp, Tomioka 2-1-1, Urayasu, Chiba 2790021, Japan
关键词
transesophageal echocardiography; patent foramen ovale; right-to-left shunt; stroke recurrence; white matter lesions; TO-LEFT SHUNT; EMBOLIC STROKE; AORTIC-ARCH; CLOSURE; PREVENTION; INFARCTION; THERAPY;
D O I
10.1016/j.jstrokecerebrovasdis.2024.108048
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Purpose: A high-risk patent foramen ovale (PFO) could be the cause of cryptogenic stroke, and an atrial septal aneurysm (ASA) increases the risk of stroke recurrence in cryptogenic stroke patients with a patent foramen ovale (PFO). Factors related to stroke recurrence according to PFO characteristics have not been fully evaluated. Methods: Data from a multicenter, observational registry of ischemic stroke patients undergoing transesophageal echocardiography were used for this study. Patients were classified into three groups: high-risk PFO, PFO with large shunt (>= 20 microbubbles) or ASA; right-to-left shunt (RLS), RLS including PFO with <20 microbubbles or without ASA, or pulmonary arteriovenous fistula; and negative RLS. Cox proportional hazards regression analysis was used to explore the factors related to stroke recurrence in these three groups. Results: In total, 586 patients (185 females; 65.5 +/- 13.2 years) were analyzed. In cryptogenic stroke (329 patients) with median follow-up of 4.2 (interquartile range, 1.0-6.1) years, 55 patients had stroke recurrence. The negative RLS, RLS, and high-risk PFO groups included 179, 90, and 60 patients, in which stroke recurrence occurred in 5.3%, 2.5%, and 4.6% per person-year, respectively. In patients with high-risk PFO, the National Institutes of Health stroke scale score (hazard ratio [HR] 1.257 [1.034-1.530]) and periventricular hyperintensity (HR 3.369 [1.103-10.294]) were predictors of stroke recurrence on multivariable Cox hazards analysis, but no factors were related to stroke recurrence in the RLS and negative RLS groups. Conclusion: Periventricular hyperintensity was shown to predict recurrent stroke in patients with a high-risk PFO.
引用
收藏
页数:8
相关论文
共 31 条
[1]   Right-to-left shunt does not increase white matter lesion load in migraine with aura patients [J].
Adami, A. ;
Rossato, G. ;
Cerini, R. ;
Thijs, V. N. ;
Pozzi-Mucelli, R. ;
Anzola, G. P. ;
Del Sette, M. ;
Finocchi, C. ;
Meneghetti, G. ;
Zanferrari, C. .
NEUROLOGY, 2008, 71 (02) :101-107
[2]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[3]   LACUNAR INFARCTION AS AN EMBOLIC COMPLICATION OF CARDIAC AND ARCH ANGIOGRAPHY [J].
CACCIATORE, A ;
RUSSO, LS .
STROKE, 1991, 22 (12) :1603-1605
[4]   Patent Foramen Ovale: Echocardiographic Detection and Clinical Relevance in Stroke [J].
Di Tullio, Marco R. .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2010, 23 (02) :144-155
[5]   Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source [J].
Diener, H. -C. ;
Sacco, R. L. ;
Easton, J. D. ;
Granger, C. B. ;
Bernstein, R. A. ;
Uchiyama, S. ;
Kreuzer, J. ;
Cronin, L. ;
Cotton, D. ;
Grauer, C. ;
Brueckmann, M. ;
Chernyatina, M. ;
Donnan, G. ;
Ferro, J. M. ;
Grand, M. ;
Kallmuenzer, B. ;
Krupinski, J. ;
Lee, B. -C. ;
Lemmens, R. ;
Masjuan, J. ;
Odinak, M. ;
Saver, J. L. ;
Schellinger, P. D. ;
Toni, D. ;
Toyoda, K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20) :1906-1917
[6]   MR SIGNAL ABNORMALITIES AT 1.5-T IN ALZHEIMER DEMENTIA AND NORMAL AGING [J].
FAZEKAS, F ;
CHAWLUK, JB ;
ALAVI, A ;
HURTIG, HI ;
ZIMMERMAN, RA .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1987, 149 (02) :351-356
[7]  
Gerriets T, 2003, AVIAT SPACE ENVIR MD, V74, P1058
[8]   INCIDENCE AND SIZE OF PATENT FORAMEN OVALE DURING THE 1ST 10 DECADES OF LIFE - AN AUTOPSY STUDY OF 965 NORMAL HEARTS [J].
HAGEN, PT ;
SCHOLZ, DG ;
EDWARDS, WD .
MAYO CLINIC PROCEEDINGS, 1984, 59 (01) :17-20
[9]   Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source [J].
Hart, R. G. ;
Sharma, M. ;
Mundl, H. ;
Kasner, S. E. ;
Bangdiwala, S. I. ;
Berkowitz, S. D. ;
Swaminathan, B. ;
Lavados, P. ;
Wang, Y. ;
Wang, Y. ;
Davalos, A. ;
Shamalov, N. ;
Mikulik, R. ;
Cunha, L. ;
Lindgren, A. ;
Arauz, A. ;
Lang, W. ;
Czlonkowska, A. ;
Eckstein, J. ;
Gagliardi, R. J. ;
Amarenco, P. ;
Ameriso, S. F. ;
Tatlisumak, T. ;
Veltkamp, R. ;
Hankey, G. J. ;
Toni, D. ;
Bereczki, D. ;
Uchiyama, S. ;
Ntaios, G. ;
Yoon, B. -W. ;
Brouns, R. ;
Endres, M. ;
Muir, K. W. ;
Bornstein, N. ;
Ozturk, S. ;
O'Donnell, M. J. ;
Basson, M. M. De Vries ;
Pare, G. ;
Pater, C. ;
Kirsch, B. ;
Sheridan, P. ;
Peters, G. ;
Weitz, J. I. ;
Peacock, W. F. ;
Shoamanesh, A. ;
Benavente, O. R. ;
Joyner, C. ;
Themeles, E. ;
Connolly, S. J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (23) :2191-2201
[10]   Embolic Stroke of Undetermined Source A Systematic Review and Clinical Update [J].
Hart, Robert G. ;
Catanese, Luciana ;
Perera, Kanjana S. ;
Ntaios, George ;
Connolly, Stuart J. .
STROKE, 2017, 48 (04) :867-872